Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Alphabet Q1 2026 Earnings Call - Cloud Revenue Hits $20B as AI Backlog Doubles to $462B
Alphabet delivered a powerhouse first quarter, posting $109.9 billion in revenue and $62.6 billion in net income, driven by a 22% year-over-year top-line increase. Google Cloud emerged as the primary ...
- Google Cloud revenue surged 63% year-over-year to $20 billion, marking the first time it exceeded $20B in a single quarter.
- Alphabet's enterprise AI solutions became the primary growth driver for Google Cloud, with revenue from products built on its own GenAI models growing nearly 800% year-over-year.
- Cloud backlog nearly doubled sequentially to $462 billion, driven by strong demand for enterprise AI offerings and the inclusion of TPU hardware sales.
- +7 more takeaways
Align Technology Q1 2026 Earnings Call - Record Aligner Volumes and Margin Expansion Outpace Macro Headwinds
Align Technology delivered a resilient Q1 2026, driven by record clear aligner volumes and disciplined execution across its global footprint. The company reported $1.04 billion in revenue, a 6.2% year...
- Total revenues reached $1.04 billion, up 6.2% year-over-year, driven by high clear aligner volumes and increased average selling prices.
- Clear aligner shipments hit a record 686,000 cases, a 6.7% year-over-year increase, with double-digit growth in international markets offsetting stability in North America.
- Clear aligner gross margin expanded 110 basis points year-over-year to 71.6%, supported by operational efficiencies and higher ASPs.
- +7 more takeaways
Alkami Q1 2026 Earnings Call - DSSP Drives 30% ARR Uplift as AI Monetization Takes Center Stage
Alkami delivered a strong first quarter with 29% revenue growth and adjusted EBITDA above expectations, fueled by the successful integration of the MANTL acquisition and accelerating adoption of its D...
- Revenue grew 29% year-over-year to $126.1 million, with subscription revenue representing 96% of total revenue.
- Adjusted EBITDA reached $22.3 million, exceeding the high end of guidance and expanding margins by 540 basis points year-over-year.
- ARR increased 22% to $494 million, with $71 million in backlog from 40 new clients expected to go live over the next 12 months.
- +9 more takeaways
Tenable Q1 2026 Earnings Call - AI Vulnerability Tsunami Fuels Exposure Management Demand
Tenable delivered a strong Q1 2026, beating guidance on every metric with 9.6% revenue growth and 24% operating margin. The company is capitalizing on a market-wide shift toward exposure management, d...
- Revenue grew 9.6% year-over-year to $262.1 million, beating the high end of guidance, while operating margin expanded to 24% (Non-GAAP).
- Tenable One, the AI-powered exposure management platform, now represents 41% of new business, up 8 percentage points year-over-year, signaling a decisive shift in customer preference.
- The company added 406 new enterprise customers and 43 net new six-figure deals in Q1, demonstrating strong new logo acquisition and large deal momentum.
- +7 more takeaways
MGM Resorts International Q1 2026 Earnings Call - Las Vegas Net Revenue Growth Returns Amid Digital Momentum and Japan Progress
MGM Resorts International delivered a resilient Q1 2026, marking its first consolidated net revenue growth in six quarters. Las Vegas top-line performance reversed a prolonged slump, supported by stro...
- Las Vegas net revenue grew year-over-year for the first time in six quarters, driven by strong convention business and a recovering leisure segment.
- MGM introduced an all-inclusive package at Luxor and Excalibur, attracting roughly one-third first-time visitors and showing positive early response.
- Segment adjusted EBITDAR in Las Vegas decreased $62 million, primarily due to a $37 million self-insurance charge and $31 million lower business interruption proceeds.
- +7 more takeaways
Phathom Pharmaceuticals Q1 2026 Earnings Call - VOQUEZNA Revenue Doubles as Gastroenterology Strategy Takes Hold
Phathom Pharmaceuticals delivered a pivotal first quarter for its core asset VOQUEZNA, with net revenues nearly doubling to $58.3 million year-over-year. The company's strategic pivot to a dedicated g...
- Net revenues surged 104% year-over-year to $58.3 million in Q1 2026, reflecting strong commercial momentum for VOQUEZNA.
- The company's dedicated gastroenterology sales force, now expanded to over 290 representatives, is effectively driving market penetration.
- VOQUEZNA achieved a remarkable 45% new-to-brand prescription market share among the top 300 gastroenterology prescribers, signaling high conversion rates.
- +7 more takeaways
Moelis & Company Q1 2026 Earnings Call - Record Revenue Driven by M&A and Private Capital Advisory Momentum
Moelis & Company delivered a record first quarter with $320 million in revenue, a 4% year-over-year increase, fueled by robust M&A and private capital advisory activity. The firm navigated near-term h...
- Moelis reported record Q1 2026 revenue of $320 million, up 4% year-over-year, driven by strong M&A and private capital advisory (PCA) performance.
- M&A revenues from financial sponsors grew double digits, signaling early momentum despite broader mid-market transactional headwinds.
- Private capital advisory is gaining traction, with a growing team of seven managing directors dedicated to GP-led and private credit secondaries.
- +12 more takeaways
Xenia Hotels & Resorts Q1 2026 Earnings Call - Raised Guidance as Broad-Based Demand Offsets World Cup Softness
Xenia Hotels & Resorts delivered a robust Q1 2026, with same-property RevPAR up 7.4% and adjusted FFO per share jumping 23.5% year-over-year. The momentum was broad-based, spanning both group and tran...
- Q1 2026 net income hit $19.8 million, with Adjusted EBITDA rising 12% to $81.4 million and adjusted FFO per share jumping 23.5% to $0.63.
- Same-property RevPAR grew 7.4%, driven by an 180 bps increase in occupancy and a 4.8% rise in average daily rate, with March being the standout month.
- Management raised full-year 2026 Adjusted EBITDAre guidance by $6 million to $266 million at the midpoint, citing broad-based demand strength.
- +9 more takeaways
The Ensign Group Q4 2025 Earnings Call - Record Occupancy and Clinical Excellence Drive 14% EPS Growth
The Ensign Group delivered another record quarter, with same-store occupancy hitting an all-time high of 83.8% and skilled days rising 8.5% year-over-year. Management attributes this surge to a relent...
- Same-store occupancy reached a record 83.8%, with transitioning occupancy at 84.9%, signaling strong organic demand and effective local market penetration.
- Clinical outcomes are a clear competitive moat, with Ensign outperforming peers by 24% in state-level CMS survey results and maintaining a 19% advantage in 4-5 star ratings.
- Acuity mix is improving rapidly, with skilled days up 8.5% and Medicare revenue up 15.7% at same-store operations, driving higher reimbursement rates.
- +7 more takeaways
Entegris Q1 2026 Earnings Call - Margin Expansion and Deleveraging Drive Structural Transformation
Entegris delivered a strong start to 2026 with Q1 revenue up 5% to $812 million, beating guidance across the board. The company posted a 46.9% gross margin, driven by manufacturing efficiency gains an...
- Q1 2026 revenue reached $812 million, a 5% year-over-year increase that exceeded the midpoint of guidance.
- Non-GAAP gross margin came in at 46.9%, beating the high end of guidance, driven by productivity gains and a useful life accounting change.
- Free cash flow surged to $144 million, representing an 18% margin, enabling a $50 million repayment on the term loan.
- +7 more takeaways